Effect of multi-strain bifidobacteria supplementation on intestinal microbiota development in low birth weight neonates: a randomized controlled trial
- PMID: 39364130
- PMCID: PMC11444860
- DOI: 10.12938/bmfh.2023-093
Effect of multi-strain bifidobacteria supplementation on intestinal microbiota development in low birth weight neonates: a randomized controlled trial
Abstract
Single-strain Bifidobacterium species are commonly used as probiotics with low birth weight neonates. However, the effectiveness and safety of multi-strain Bifidobacterium supplementation are not well known. Thirty-six neonates weighing less than 2,000 g (558-1,943 g) at birth and admitted to a neonatal intensive care unit were randomly assigned to receive a single strain or triple strains of Bifidobacterium with lactulose enterally for 4 weeks from birth. The relative abundances of Staphylococcus and Bifidobacterium in the fecal microbiota at weeks 1, 2, and 4 were investigated. Based on the study results, no significant difference was detected between the two groups in the abundance of Staphylococcus; however, the triple-strain group had significantly high abundances of Bifidobacterium at weeks 2 and 4. The fecal microbiota in the triple-strain group had significantly lower alpha diversity (Bifidobacterium-enriching) after week 4 and was different from that in the single-strain group, which showed a higher abundance of Clostridium. No severe adverse events occurred in either group during the study period. Although no significant difference was detected between single- and multi-strain bifidobacteria supplementation in the colonization of Staphylococcus in the fecal microbiota of the neonates, multi-strain bifidobacteria supplementation contributed toward early enrichment of the microbiota with bifidobacteria and suppression of other pathogenic bacteria, such as Clostridium spp.
Keywords: gut microbiota; low birth weight neonates; multi-strain bifidobacteria; probiotics.
©2024 BMFH Press.
Conflict of interest statement
Morinaga Milk Industry Co., Ltd. was not the sponsor of this study but did supply the probiotic products free of cost for the trial.
Figures
Similar articles
-
The prebiotic effect of 1-kestose in low-birth-weight neonates taking bifidobacteria: a pilot randomized trial in comparison with lactulose.Biosci Microbiota Food Health. 2024;43(4):329-335. doi: 10.12938/bmfh.2023-079. Epub 2024 May 20. Biosci Microbiota Food Health. 2024. PMID: 39364124 Free PMC article.
-
Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.Anaerobe. 2013 Oct;23:38-44. doi: 10.1016/j.anaerobe.2013.08.002. Epub 2013 Aug 26. Anaerobe. 2013. PMID: 23988359
-
Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome.Am J Clin Nutr. 2017 Nov;106(5):1274-1286. doi: 10.3945/ajcn.117.157529. Epub 2017 Sep 6. Am J Clin Nutr. 2017. PMID: 28877893 Clinical Trial.
-
Immunology and probiotic impact of the newborn and young children intestinal microflora.Anaerobe. 2011 Dec;17(6):369-74. doi: 10.1016/j.anaerobe.2011.03.010. Epub 2011 Apr 16. Anaerobe. 2011. PMID: 21515397 Review.
-
Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials.J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):203-9. doi: 10.1097/MPG.0b013e3181dc0d93. J Pediatr Gastroenterol Nutr. 2010. PMID: 20543719 Free PMC article. Review.
References
-
- Tamburini S, Shen N, Wu HC, Clemente JC. 2016. The microbiome in early life: implications for health outcomes. Nat Med 22: 713–722. - PubMed
-
- Stewart CJ, Marrs ECL, Magorrian S, Nelson A, Lanyon C, Perry JD, Embleton ND, Cummings SP, Berrington JE. 2012. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr 101: 1121–1127. - PubMed
-
- Murgas Torrazza R, Neu J. 2011. The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol 31Suppl 1: S29–S34. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous